Same Indication

Pravastatin vs Tofacitinib

Pravastatin vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Pravastatin and Tofacitinib.

Mechanism of Action

Pravastatin: Competitive inhibitor of HMG-CoA reductase.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Pravastatin — 1.8 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Pravastatin — C23H36O7; Tofacitinib — C16H20N6O.

Molecular Weight: Pravastatin — 424.5280 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Pravastatin — Small molecule; Tofacitinib — Small molecule.